The Carlat Psychiatry Report

Search   Archives Medication Fact Sheets Newsletter Articles

ADHD   

Antidepressants   

Antipsychotics   

Anxiety Disorders   

Benzodiazepines   

Bipolar disorder   

Brain Devices   

Child Psychiatry   

Computers in Psychiatric Practice   

Dementia   

Depressive Disorders   

Eating Disorders   

Genetics and psychiatry   

HIPAA tips   

Hypnotics   

Laboratory Testing in Psychiatry   

Natural treatments   

Neuroscience in Psychiatry   

OCD   

Pharmaceutical Industry   

Psychopharmacology Tips   

Psychotherapy   

PTSD   

Research Updates   

Seasonal Affective Disorder   

Sexual Dysfunction   

Substance abuse   

Understanding Psychiatric Research   

Women's Issues in Psychiatry   

Tales from the
History of
Psychiatry
 

NEW! View media coverage of Dr. Carlat and TCPR. And click here to read his blog on psychiatry and the pharmaceutical industry.

For information about website access for members of the press, please click here.

Featured ArticleFeatured Articles

After many years of trying, Wyeth finally received FDA approval for its new antidepressant, Pristiq (desvenlafaxine.)  Don't get too excited though-Pristiq is simply the active metabolite of Effexor... (Subscription required) 
 
The National Institute on Alcohol Abuse and Alcoholism has recently posted a practical guide for professional interested in improving their skills in evaluating and treating patients with alcohol problems.  Learn more here… (Free.)  
 
"To sleep, perchance to dream-ay, there is the rub."  Hamlet may have feared sleep, but for the millions of Americans suffering from chronic sleeping problems, they fear not sleeping.  Clearly sleeping pills work, find out here whether there are significant differences among them.  (Subscription required) 

Combining Meds for Depression:
The State of the Art

Most psychiatrists prescribe SSRIs as the first-line medication for depression, but what's the best option when this strategy is ineffective? Here's a run-down of the best antidepressant combinations. (Free)

Invega: Can You Say “Patent Extender”?
Invega (paliperidone) is the newest antipsychotic to be approved by the FDA. But is it really “new”? In this article, we analyze the pros and cons of Invega, particularly in comparison with its mother compound, risperidone.(Free)

What's New in Eating Disorders?
While few psychiatrists specialize in eating disorders, most of us see patients with anorexia or bulimia from time to time. It's hard to keep up on the latest literature when we see such patients rarely. Here's an update on issues of diagnosis and treatment. (Free)

Laboratory Monitoring When Prescribing Psychotropics
When you are planning to start a patient on medications, what labs should you order? (Free.)

Typical Antipsychotics: A Brief Review
Those of us who completed residency anytime during the last 10 years were indoctrinated against the use of conventional neuroleptics because of their array of side effects, particularly extrapyramidal syndromes (EPS) and tardive dyskinesia (TD). But the results of the CATIE trial endorsed the usefulness of Trilafon (perphenezine), prompting us to take another look at the typical antipsychotics. (Free)

Antidepressants: Does Mechanism Matter?
It would be nice if we knew how antidepressants worked. But to be honest, we don’t. Here’s a review of some of the more hotly debated issues in the ongoing conversation about neurotransmitters. (Free)  

Subscribe Now

First time subscribers sign up now to get a $30 discount plus a FREE Medication Fact Book!

Go Subscribe Now More Info

This Month's
Issue:

(Current subscribers only.)

Vol. 6, No. 5   May 2008

Focus of the Month:
Neuropsychological Testing

The MoCA:  A Better MMSE?

Test to Detect Malingering

Research Updates

Computerized Tests for ADHD

Expert Q & A:  Buck Woo, Ph.D.  The Utility of Neuropsychological Testing

 

 

 


New Book!

Drug Metabolism in Psychiatry, 2nd Edition

Drug Metabolism in Psychiatry: A Clinical Guide
By Daniel Carlat M.D.

Go Subscribe Now Buy now!


SPECIAL!

for Carlat Subscribers!

Order any Guilford Press book, periodical, video, or software product through December 31, 2008 and take 15% off the list price.

Click here for more information and for the Promotional Code

  
Copyright © 2003-2007 Clearview Publishing, LLC
The Carlat Psychiatry Report, All Rights Reserved.


Site Development, Hosting and Dynamic Framework: Portside Technologies, Inc.

Graphical design by Eyeland Creations
Login